| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/12/2012 | WO2012005376A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 01/12/2012 | WO2012005368A1 Single-strand nucleic acid molecule for controlling gene expression |
| 01/12/2012 | WO2012005339A1 Prophylactic or therapeutic agent for diabetes |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011117258A3 Methods of increasing efficiency of vector penetration of target tissue |
| 01/12/2012 | WO2002036070A3 Novel fish chemokine and methods for use |
| 01/12/2012 | US20120010276 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 01/12/2012 | US20120010275 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 |
| 01/12/2012 | US20120010273 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 01/12/2012 | US20120010270 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) |
| 01/12/2012 | US20120010269 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 |
| 01/12/2012 | US20120010268 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009267 Nanoparticle compositions and methods for improved oral delivery of active agents |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009246 Phospholipid-analogous compounds |
| 01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009161 Therapeutic retroviral vectors for gene therapy |
| 01/12/2012 | DE19925052B4 Proteinkomplexe für den zielgerichteten Transport von (Poly)Peptide und Nukleinsäuren und sequenzspezifische Integration von DNA-Vektoren Protein complexes for targeted transport of (poly) peptides and nucleic acids and sequence-specific integration of DNA vectors |
| 01/12/2012 | CA2804815A1 Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery |
| 01/12/2012 | CA2804511A1 Single-stranded nucleic acid molecule for controlling gene expression |
| 01/12/2012 | CA2804492A1 Immunisation of large mammals with low doses of rna |
| 01/12/2012 | CA2804271A1 Prophylactic or therapeutic agent for diabetes |
| 01/12/2012 | CA2803787A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 01/12/2012 | CA2800679A1 Compositions and methods for enhancement of nucleic acid delivery |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2405001A1 Nucleic acid complex and nucleic acid-delivering composition |
| 01/11/2012 | EP2404997A1 Method for enhancing function of t cell |
| 01/11/2012 | EP2403943A1 Vangl1 peptides and vaccines including the same |
| 01/11/2012 | EP2054515B1 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/11/2012 | EP1986696B1 Method for production of a transformed cell |
| 01/11/2012 | EP1907015B1 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 01/11/2012 | EP1572074B1 Stabilized synthetic immunogen delivery system |
| 01/11/2012 | EP1565210B1 Clostridial neurotoxin for use in the treatment of nasal congestion |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1402070B1 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/11/2012 | EP1180932B1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | CN1948483B SiRNA for inhibiting human Rabj gene expression and its application |
| 01/11/2012 | CN1948482B Antisensedigonucleotides sequence for inhibiting human Rabj gene expression and its application |
| 01/11/2012 | CN102317469A GNAQ mutations in melanoma |
| 01/11/2012 | CN102317458A Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO |
| 01/11/2012 | CN102311956A Specific base modification antisense nucleotide chain and application thereof |
| 01/11/2012 | CN102311501A Fusion protein comprising GLP-1 (Glucagon-Like Peptide) or analog thereof and preparation method as well as application thereof |
| 01/11/2012 | CN102309762A Preparation method for lactosaminated carboxymethyl chitosan magnetic nano-particle gene vector |
| 01/11/2012 | CN102309757A Novel regulatory factor of FOXP3 and regulatory T cells, and use thereof |
| 01/11/2012 | CN101935640B Bacterial colony induction signal degrading enzyme and coding gene and application thereof |
| 01/11/2012 | CN101864452B Double-specificity anti-tumor recombinant adenovirus and construction method and application thereof |
| 01/11/2012 | CN101721715B Compound of tumor targeted nonviral gene vector and plasmid DNA and preparation method thereof |
| 01/11/2012 | CN101591657B Thymosin beta4 gene expression inhibiting RNA and use thereof |
| 01/11/2012 | CN101422617B Use of ZNF268 gene splicing isomer in treating leukaemia |
| 01/11/2012 | CN101220373B Recombined viral vectors and uses thereof |
| 01/10/2012 | US8093370 siRNA targeting spleen tyrosine kinase |
| 01/10/2012 | US8093225 Gene expression and pain |
| 01/10/2012 | US8093224 Antisense modulation of C-reactive protein expression |
| 01/10/2012 | US8093223 RIP140 regulation of diabetes |
| 01/10/2012 | US8093221 Slimming body milk; reducing cellulite and/or orange peel appearance |
| 01/10/2012 | US8093205 Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis |
| 01/10/2012 | US8093054 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 01/10/2012 | US8093043 β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis |
| 01/10/2012 | US8093042 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 01/10/2012 | US8092992 Transcriptional regulation of gene expression by small double-stranded modulatory RNA |
| 01/10/2012 | US8092833 Compositions containing inclusion complexes |
| 01/10/2012 | US8092809 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/10/2012 | US8092791 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
| 01/10/2012 | US8092781 Treatment of sinusitis in mammals with clostridia neurotoxins |
| 01/10/2012 | CA2597701C Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 01/10/2012 | CA2455189C Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2392071C Microparticle-based transfection and activation of dendritic cells |
| 01/10/2012 | CA2354029C Gene therapy for cardiomyopathy |
| 01/10/2012 | CA2222328C Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 01/05/2012 | WO2012003287A2 Compositions and methods for detecting and quantifying circulating tumor cells ctcs |
| 01/05/2012 | WO2012001170A1 Telomerase reverse transcriptase for protection against ageing |
| 01/05/2012 | WO2011140595A3 Immunostimulatory and vaccine compositions |
| 01/05/2012 | WO2011135141A4 Modified oligonucleotides as regulators of gene expression |
| 01/05/2012 | WO2011125055A3 Synthetic constructs for polynucleotide and protein expression |
| 01/05/2012 | WO2011116371A3 Polyplex gene delivery vectors |
| 01/05/2012 | WO2011103345A3 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor |
| 01/05/2012 | WO2011097582A3 Treatment of arachidonate 12-lipoxygenase, 12r type (alox12b) related diseases by inhibition of natural antisense transcript to alox12b |
| 01/05/2012 | WO2011094358A9 Influenza nucleic acid molecules and vaccines made therefrom |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | WO2002026936A9 Gene expression in the central nervous system regulated by neuroleptic agents |
| 01/05/2012 | US20120005768 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD) |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120003278 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | US20120003276 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 01/05/2012 | US20120003264 CDNA Corresponding to the Antigenome of Nonsegmented Negative Stranded RNA Viruses and Process for the Production of Such Viruses |
| 01/05/2012 | US20120003233 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 01/04/2012 | EP2402451A2 Method for stabilizing an DNA insert in a recombinant vaccinia vector |
| 01/04/2012 | EP2402444A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 01/04/2012 | EP2402442A2 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 01/04/2012 | EP2402038A1 Telomerase reverse transcriptase for protection against ageing |
| 01/04/2012 | EP2402033A1 Cell adhesion inhibitor and use thereof |
| 01/04/2012 | EP2401376A2 Piggybac transposon variants and methods of use |
| 01/04/2012 | EP2401374A1 Means and methods for durable inhibition of pathogens |